Dr. Samir Gautam, MD

Dr. Gautam practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Gautam's NPI, 1275766396, was assigned on August 24, 2009. Dr. Gautam holds Maryland license D77622.

Dr. Gautam's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Gautam's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Gautam is also affiliated with The Johns Hopkins Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Gautam to 3 more hospitals, 2 dialysis centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gautam practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gautam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Gautam's licenses on file in 3 states: Maryland, Louisiana and Mississippi.

CMS data shows 1,291 Medicare services from Dr. Gautam across 10 procedure codes in 2024, for 441 Medicare patients. Medicare paid $96,803 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 441 Medicare patients who saw Dr. Gautam in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 5.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gautam's median patient age at 71, with 46% women.

In 2024, Dr. Gautam wrote 218 Medicare Part D claims for 49 patients. 82% of them were for generic drugs. CMS names the drug for 107 of them, across 6 drugs with 11 or more claims each, at $16,959 in total drug cost. In 2023, CMS named 71 claims across 4 drugs.

CMS lists Dr. Gautam as offering telehealth.

Dmand AI links 41 papers to Dr. Gautam, published from 2012 to 2024. 2024 was the busiest year, with 7. The most frequent topics are Acute Kidney Injury, Renal Dialysis and Nepal. Dr. Gautam has published most often in Kidney360. Dr. Gautam's most frequent co-authors are Samir Gautam, MD, PhD, Avi Cohen, MD and David Spiegel, MD.

CMS Open Payments shows 75 general payments to Dr. Gautam from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Keryx Biopharmaceuticals, Inc. paid the most, $323.